"On June 2, 2023, the Governor signed into law Senate Bill 14 (the “Healthcare Ban”), a law that prohibits healthcare providers from providing patients under 18 with critical, medically necessary, evidence-based treatments for gender dysphoria.2 Denying such evidence-based medical care to adolescents who meet the requisite medical criteria puts them at risk of significant harm. Below, amici provide the Court with an accurate description of the relevant treatment guidelines and summarize the scientific evidence supporting the medical interventions for adolescents prohibited by the Healthcare Ban."
Read the BriefJuly 19, 2024
The US House of Representatives will vote on the appropriations bill responsible for funding the NIH, CDC, and other health agencies. We need your voice to strengthen our message about the harms of this bill.
May 20, 2024
The Endocrine Society submitted testimony regarding Fiscal Year (FY) 2025 funding levels for NIH, Title X, and CDC.
May 02, 2024
The Endocrine Society submitted testimony regarding Fiscal Year (FY) 2025 funding levels for NIH, Title X, and CDC.
May 01, 2024
We join with other leading medical organizations to educate the court in Illinois about standards of care for incarcerated individuals with gender dysphoria.
August 11, 2023
We provide the court in Texas with information about the standards of care and appropriate treatment for gender dysphoria in adolescents.
We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your US representatives or European Members of Parliament through our online platform. Take action and make a difference today.
